IONIS PHARMACEUT reported $133.79M in Sales Revenues for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Agios Pharmaceuticals AGIO:US $ 5.58M 4.75M
Alnylam Pharmaceuticals ALNY:US $ 224.82M 11.56M
Arrowhead Research ARWR:US $ 32.41M 119.39M
Astellas Pharma 4503:JP Y 381791M 77921M
Biocryst Pharmaceuticals BCRX:US $ 65.53M 15.61M
Biomarin Pharmaceutical BMRN:US $ 533.8M 14.44M
Bluebird Bio BLUE:US $ 1.52M 0.43M
Esperion Therapeutics ESPR:US $ 18.84M 5K
Exelixis EXEL:US $ 419.43M 63.45M
Halozyme Therapeutics HALO:US $ 152.36M 35.09M
Intercept Pharmaceuticals ICPT:US $ 71.76M 16.82M
Mirati Therapeutics MRTX:US $ 5.36M 4.65M
Moderna Inc MRNA:US 4.75B 1.32B
Nektar Therapeutics NKTR:US $ 21.58M 3.24M
Neurocrine Biosciences NBIX:US $ 378.2M 67.6M
Novartis NOVN:VX SF 13085M 271M
Pfizer PFE:US $ 27742M 2081M
Ptc Therapeutics PTCT:US $ 165.53M 16.79M
Regeneron Pharmaceuticals REGN:US $ 2857.2M 107.9M
Roche Holding ROG:VX 16.44B 474M
Sarepta Therapeutics SRPT:US $ 233.49M 22.66M
Ultragenyx Pharmaceutical RARE:US $ 89.34M 9.41M
Vertex Pharmaceuticals VRTX:US $ 2196.2M 98.7M